Article, Finance, Manufacturing and Provider

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Article

Finance

Manufacturing

Provider

Ep. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D., of Roetzel & Andress

Physician's Practice

JUNE 9, 2025

68: Hidden risks of prescribing GLP-1 drugs with Ericka L. **Financial Relationships with Pharmaceutical Companies (00:20:10)** Legal and ethical concerns for physicians with financial ties to GLP-1 drug manufacturers, including anti-kickback laws. Transform interactions into lasting connections. 65: Patient autonomy with Jeffrey A.

Management

Management Telemedicine Patients Insurance

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

SEPTEMBER 13, 2021

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate. Court of Appeals (again, see our post ).

Manufacturing

Manufacturing Supply Chain Patient-Centered Utilities

Webinars

How to Start Virtual Care the Right Way: A Proven Roadmap for 2025 and Beyond

MORE WEBINARS

Primary Care Digest

Ep. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D., of Roetzel & Andress

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

Webinars

Stay Connected